Microcystic adnexal carcinoma misdiagnosed as a "recurrent epidermal cyst": A case report. [PDF]
Yang SX, Mou Y, Wang S, Hu X, Li FQ.
europepmc +1 more source
International Dermoscopy Society consensus recommendations for the management of lentigo maligna
Lentigo maligna (LM) poses diagnostic and therapeutic challenges amid rising incidence and limited high‐quality evidence. This international expert consensus provides pragmatic, evidence‐based and expertise‐informed guidance on LM diagnosis and management.
Ana‐Maria Forsea +52 more
wiley +1 more source
Skin adnexal carcinoma with BRD3-NUTM2B fusion. [PDF]
Rubio Gonzalez B +3 more
europepmc +1 more source
Matrix Metalloproteinase 28-Bearing Microcystic Adnexal Carcinoma on the Back. [PDF]
Chiba H +4 more
europepmc +1 more source
Four calcium signaling pathway-related genes were upregulated in microcystic adnexal carcinoma: transcriptome analysis and immunohistochemical validation. [PDF]
Yu S +7 more
europepmc +1 more source
Microcystic Adnexal Carcinoma of the Lower lip: A Case Report
PURPOSE: Microcystic adnexal carcinoma is a rare malignant appendage tumor, first described by Goldstein et al in 1982. Here, we present our experience in treatment of a case on the lower lip.
나동균, 탁관철
core
Treatment options for ocular adnexal lymphoma (OAL)
Victoria Mary Lendrum CohenSt. Bartholomew’s and Moorfields Eye Hospital, London UKAbstract: Most lymphomas that involve the ocular adnexal structure are low grade, B cell, non-Hodgkin’s lymphomas. The treatment depends upon the grade
Victoria Mary Lendrum Cohen
core
Microcystic adnexal carcinoma (MAC) is a rare cutaneous neoplasm, locally aggressive, recently recognized as a clinicopathologic entity. Histologically, MAC shows both ductal and pilar differentiation.
Politi M. +4 more
core
Facial microcystic adnexal carcinoma - treatment with a "jigsaw puzzle" advancement flap and immediate esthetic reconstruction: A case report. [PDF]
Xiao YD, Zhang MZ, Zeng A.
europepmc +1 more source
Microsecretory adenocarcinoma (MSA) was first described in 2019 as a low-grade salivary gland neoplasm of intraoral origin with distinct histopathologic features and a characteristic MEF2C::SS18 fusion.
Vellaichamy, Gautham +3 more
core +1 more source

